Autoantibodies against N-terminal EF-hand calcium-binding protein 1 in neurological syndromes and cancer

Abstract Background Paraneoplastic neurological syndromes (PNS) are immune-mediated disorders associated with cancer and often precede tumor diagnosis. Identification of novel neural autoantigens may facilitate diagnosis and treatment. Methods Sera or cerebrospinal fluid (CSF) from six patients showing a similar uncharacterized immunofluorescence staining pattern on rat hippocampal sections were collected. The target antigen was identified by immunoprecipitation and mass spectrometry and validated using established immunoassays. Results N-terminal EF-hand calcium-binding protein 1 (NECAB1) was revealed as target of the autoantibodies. Antigen identification was validated by competitive tissue IIFA, CBA, Western blot and line blot with the recombinant antigen. No reactivity was observed in CBA and line blot with 100 healthy controls or CBA with 303 disease controls. All five clinically characterized patients had breast or lung cancer and presented with limbic encephalitis ( n = 3), cerebellar ataxia with cognitive decline ( n = 1), or sensory-motor neuronopathy ( n = 1). Conclusions NECAB1 represents a novel autoantibody target in autoimmune neurological syndromes associated with lung or breast cancer. Samples from patients with suspected neurological autoimmune disorder showing the specific hippocampal interneuron IIFA pattern should be analyzed for NECAB1 autoantibodies by CBA or line blot and cancer screening should be considered.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2026-11-14
DOI
https://doi.org/10.1007/s00415-026-14257-3
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Autoantibodies against N-terminal EF-hand calcium-binding protein 1 in neurological syndromes and cancer

Géraldine Picard, Christiane Radzimski, Kathrin Borowski, Ramona Miske et al.
Journal of Neurology
Autoimmune Neurological Disorders and Treatments
article

Autoantibodies against N-terminal EF-hand calcium-binding protein 1 in neurological syndromes and cancer

Géraldine Picard, Christiane Radzimski, Kathrin Borowski, Ramona Miske, Jérôme Honnorat, J. Granja López, Anne‐Laurie Pinto, Madeleine Scharf, Yvonne Müller, Le Duy Do, Henning Bagelmann, Lars Komorowski, Monika Baloun
article en

Abstract

Abstract Background Paraneoplastic neurological syndromes (PNS) are immune-mediated disorders associated with cancer and often precede tumor diagnosis. Identification of novel neural autoantigens may facilitate diagnosis and treatment. Methods Sera or cerebrospinal fluid (CSF) from six patients showing a similar uncharacterized immunofluorescence staining pattern on rat hippocampal sections were collected. The target antigen was identified by immunoprecipitation and mass spectrometry and validated using established immunoassays. Results N-terminal EF-hand calcium-binding protein 1 (NECAB1) was revealed as target of the autoantibodies. Antigen identification was validated by competitive tissue IIFA, CBA, Western blot and line blot with the recombinant antigen. No reactivity was observed in CBA and line blot with 100 healthy controls or CBA with 303 disease controls. All five clinically characterized patients had breast or lung cancer and presented with limbic encephalitis ( n = 3), cerebellar ataxia with cognitive decline ( n = 1), or sensory-motor neuronopathy ( n = 1). Conclusions NECAB1 represents a novel autoantibody target in autoimmune neurological syndromes associated with lung or breast cancer. Samples from patients with suspected neurological autoimmune disorder showing the specific hippocampal interneuron IIFA pattern should be analyzed for NECAB1 autoantibodies by CBA or line blot and cancer screening should be considered.

Journal of NeurologyVol. 273(12)
Université Claude Bernard Lyon 1 (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Lyon (FR), Hospices Civils de Lyon (FR), Euroimmun Medizinische Labordiagnostika (Germany) (DE), Freiberger Compound Materials (Germany) (DE), Mécanismes en sciences intégratives du vivant (FR), TU Bergakademie Freiberg (DE)
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon